Invited review: Application of omics tools to understanding probiotic functionality  by Baugher, J.L. & Klaenhammer, T.R.
4753
J. Dairy Sci.  94 :4753–4765
doi: 10.3168/jds.2011-4384 
© American Dairy Science Association®,  2011 .
 ABSTRACT 
 The human gut microbiota comprises autochthonous 
species that colonize and reside at high levels perma-
nently and allochthonous species that originate from 
another source and are transient residents of the human 
gut. The interactions between bacteria and the human 
host can be classified as a continuum from symbiosis 
and commensalism (mutualism) to pathogenesis. Probi-
otics are live microorganisms that, when administered 
in adequate amounts, confer a health benefit on the 
host. Recent advances in omics tools and sequencing 
techniques have furthered our understanding of probi-
otic functionality and the specific interactions between 
probiotics and their human hosts. Although it is known 
that not all probiotics use the same mechanisms to 
confer benefits on hosts, some specific mechanisms of 
action have been revealed through omic investigations. 
These include competitive exclusion, bacteriocin-medi-
ated protection against intestinal pathogens, intimate 
interactions with mucin and the intestinal epithelium, 
and modulation of the immune system. The ability 
to examine fully sequenced and annotated genomes 
has greatly accelerated the application of genetic ap-
proaches to elucidate many important functional roles 
of probiotic microbes. 
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 INTRODUCTION 
 Humans and their collective microbiomes have been 
termed “superorganisms” because of their close symbi-
otic relationships (Gill et al., 2006). The human micro-
biome contains an estimated 100 trillion microbes, 10 
times as many cells as the human body, and may con-
tain up to 100-fold more unique genes than the human 
complement (Ley et al., 2006). With the vast major-
ity of the bacteria residing within the gastrointestinal 
tract, the composition of the human gut microbiota 
includes autochthonous species that colonize and reside 
at high levels permanently; normal species that can 
vary greatly in number and may be sporadically absent; 
pathogenic species that are periodically acquired from 
the environment; and allochthonous species that origi-
nate from another source and are transient residents of 
the human gut (Backhed et al., 2005). The interactions 
between bacteria and the human host involve a diverse 
microbiota that occupy varied environments and rep-
resent a continuum from symbiosis and commensalism 
(mutualism) to pathogenesis. 
 Among the variable microbial components of the 
human gut microbiota are health-promoting, mucosa-
adherent species. Probiotics are “live microorganisms, 
which when administered in adequate amounts confer 
a health benefit on the host” (FAO/WHO, 2001). Be-
cause of their health benefits, probiotic bacteria are 
now a vital component in the multi-billion dollar dairy 
and functional foods industry. Probiotic bacteria can 
be added as commercial probiotic starter cultures or 
selected in naturally fermented foods; the best studied 
and most widely used commercial probiotic species 
belong to the genera Bifidobacterium and Lactobacillus
(Felis and Dellagio, 2007; Kleerebezem and Vaughan, 
2009). Although not all probiotic cultures confer iden-
tical benefits on hosts, the potential mechanisms of 
action include competitive exclusion, maintenance of 
barrier function, metabolic and antimicrobial effects, 
enhancement of a balanced microbial flora, modulation 
of signal transduction, and immunomodulation of innate 
or adaptive immunity (Sherman et al., 2009). Specific 
roles and benefits of probiotics in the gastrointestinal 
tract (GIT; Table 1) include protection against infec-
tion (Corr et al., 2007), lowered cold and influenza-like 
symptoms in children (Leyer et al., 2009), lowering of 
blood cholesterol levels (Ataie-Jafari et al., 2009), and 
suppression of allergic asthma (Aumeunier et al., 2010). 
Despite strong evidence for the functional claims of 
probiotics, poor characterization of the specific molecu-
lar mechanisms by which these probiotic microbes elicit 
health benefits underlies the skepticism of the validity 
of these findings in the biomedical community. 
 Recent advances in omics and integrated functional 
genomic analyses involving transcriptomics, proteomics, 
secretomics, metabolomics, and interactomics have ac-
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celerated the research into deciphering specific mecha-
nisms for commensal and probiotic functionality within 
the GIT. Since the first bacterial genome (Haemophilus 
influenzae) was completely sequenced in 1995, sequenc-
ing technology has experienced an exponential increase 
in processing speed, at significantly lowered costs, 
yielding more than 1,300 completed bacterial genome 
sequences (National Center for Biotechnology Informa-
tion; http://www.ncbi.nlm.nih.gov/). With increasing 
interest in the benefits and the applications of lactic acid 
bacteria and probiotic microbes, the Lactic Acid Bacte-
ria Genome Consortium (LABGC) and numerous food 
and pharmaceutical companies have sequenced a broad 
range of health-promoting and industrially relevant 
strains (Liu et al., 2005). The first probiotic microbe 
to be sequenced was Bifidobacterium longum NCC2705 
(Schell et al., 2002), followed shortly by a procession of 
important lactic acid bacterial strains, including Lacto-
bacillus plantarum WCSF1 (Kleerebezem et al., 2003), 
Streptococcus thermophilus CNRZ1066 (Bolotin et al., 
2004), Lactobacillus acidophilus NCFM (Altermann 
et al., 2005), Lactobacillus casei ATCC334 (Makarova 
et al., 2006), Lactobacillus gasseri ATCC33323 (Ma-
karova et al., 2006), Lactobacillus salivarius UCC118 
(Claesson et al., 2006), and Lactobacillus rhamnosus 
GG (Kankainen et al., 2009). The availability of rapid, 
cost-effective sequencing technology has fostered a new 
area, termed “probiogenomics,” which has significantly 
expanded our knowledge about the evolution of com-
mensal and probiotic bacteria and their genetic diver-
sity, and in some cases has elucidated the molecular 
basis for health-promoting functions. Understanding in-
timate microbe–microbe and host–microbe interactions 
within the GIT has been facilitated by the integration 
of probiogenomics and functional genomic analyses of 
human gene expression within the gut (Ventura et al., 
2009). These new omics technologies allow simultane-
ous analysis of great numbers of genes and proteins 
from both host and microbe (Joyce et al., 2006).
The focus of this review is to highlight landmark 
studies that have applied integrated omics tools to fur-
ther the understanding of probiotic functionality and 
the specific interactions between probiotics and their 
human hosts.
Metagenomic Sequencing of Gut Microbiota
Fecal samples of 124 individuals of European (Nordic 
and Mediterranean) origin were collected to establish 
a catalog of nonredundant human intestinal microbial 
genes (Qin et al., 2010). Utilizing Illumina (San Di-
ego, CA; formerly Solexa) genome analyzer short-read, 
metagenomic-based sequencing, the gene set was found 
to be 150 times larger than the human gene comple-
ment. With over 99% of the genes in the set being 
bacterial, the cohort of the study included between 
1,000 and 1,150 prevalent bacterial species, with each 
individual containing at least 160 of such bacterial spe-
cies. By developing an extensive nonredundant catalog 
of the bacterial genes, vital functions for a bacterium 
to thrive in a gut context were identified (“minimal 
gut genome”). Within the minimal gut genome, 2 
major gene types were identified: housekeeping genes, 
required for carbon metabolism, amino acid synthesis, 
and protein complexes, and genes specific to life within 
the GIT (Qin et al., 2010). The most commonly shared 
gut-specific functions of members of the microbiome 
community were functions promoting interactions with 
the host epithelium such as adherence to collagen, fi-
brinogen, and fibronectin, and sugar metabolism (Qin 
et al., 2010).
Interestingly, within the fecal samples of the cohort, 
the sequences for the lactic acid bacterium Streptococ-
cus thermophilus were among the 57 most frequent 
Table 1. Role and benefits of probiotics in the gastrointestinal tract1 
Benefits of probiotic bacteria Reference
Protection against infection Corr et al., 2007
Lowered incidence of diarrhea Lonnermark et al., 2010
Lowered levels of cold and influenza-like symptom in children and reduction of missed school days Leyer et al., 2009
Antimicrobial activity Ryan et al., 2009
Competitive exclusion of pathogens Lee et al., 2003
Immune tolerance van Baarlen et al., 2009
Suppression of allergic asthma and autoimmune diabetes Aumeunier et al., 2010
Reduction in colorectal cancer biomarkers Rafter et al., 2007
Return to pre-antibiotic baseline flora Engelbrektson et al., 2009
Epithelial barrier function Mennigen et al., 2009
Increased cellular immunity (e.g., increased natural killer cell activity) Takeda and Okumura, 2007
Increased humoral response (e.g., IgA secretion) Viljanen et al., 2005
Lowering of blood cholesterol levels Ataie-Jafari et al., 2009
Reduction in irritable bowel disease symptoms Macfarlane et al., 2009
Suppression of inflammatory autoimmune disorders Kwon et al., 2010
Delivery of therapeutics Wells and Mercenier, 2008
1Modified from O’Flaherty and Klaenhammer (2010).
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species found in the human microbiome. Streptococcus 
thermophilus, used in yogurt and cheese manufactur-
ing, is considered the second most widely used starter 
culture in the manufacturing of dairy products (Hols 
et al., 2005). Beneficial functions performed by Strep. 
thermophilus include efficiently breaking down lactose 
and activating host CD4+ and CD8+ lymphocytes that 
stimulate IFN-γ production in tissue-cultured cells 
(Aattouri and Lemonnier, 1997). Thermophilin 9, a 
class II bacteriocin produced by Strep. thermophilus 
LMD-9, displays an inhibitory spectrum that is effec-
tive against related gram-positive bacteria, including 
pathogens such as Listeria monocytogenes (Fontaine 
and Hols, 2008).
A significant difference has been reported between 
the microbiota of patients with inflammatory bowel 
disease (IBD) and healthy individuals (Manichanh et 
al., 2006). The link between individuals’ health status 
(healthy, Crohn disease, and ulcerative colitis) and 
species abundance was tested, using an Illumina-based 
bacterial profiling. A clear differentiation between pa-
tients of each health status confirmed the hypothesis 
that a significant difference existed in the microbiota 
of IBD patients and healthy individuals. A major Fir-
micute representative of the gut microbiota, Fecalibac-
terium prausnitzii (member of the Clostridium leptum 
group) was found in abundance in each individual of 
the cohort who did not have IBD symptoms (Qin et al., 
2010). The presence of F. prausnitzii could be crucial 
to the homeostasis of the gut because a species reduc-
tion was consistently associated with increased suscep-
tibility of the gut mucosa in patients suffering from 
IBD and infectious colitis (Sokol et al., 2009). Orally 
administering either F. prausnitzii cells or supernatant 
reduced the severity of 2,4,6-trinitrobenzenesulfonic 
acid (TNBS)-induced colitis in mice and stabilized the 
overall dysbiosis of the gut. Secreted metabolites found 
in the supernatant effectively blocked nuclear factor-κB 
activation and other inflammatory cytokines (Sokol et 
al., 2008).
The following are specific examples of omics applica-
tions that have revealed important mechanisms under-
lying activities elicited by probiotic microbes, allowing 
for the validation and enhancement of conferred host 
benefits.
Antimicrobial Activity
Probiotic cultures have long been considered to exert 
protective effects against pathogens via direct antago-
nism or competitive exclusion. Lactobacillus salivarius 
has been isolated from the intestinal mucosa of 9% of 
all humans sampled (Molin et al., 1993). Lactobacil-
lus salivarius UCC118 was originally isolated from a 
sample of the terminal ileum (distal part of the small 
intestine) of a healthy participant. Studied for its pro-
biotic benefits in humans and animal models (Dunne 
et al., 2001; Sheil et al., 2004), Lb. salivarius UCC118 
has been shown to alleviate gastrointestinal infections 
such those caused by Citrobacter rodentium, Salmonella 
typhimurium and Helicobacter pylori, (Johnson-Henry 
et al., 2005; O’Hara et al., 2006; Ryan et al., 2008). De-
spite the health benefits of Lb. salivarius UCC118 being 
well established, the precise mechanisms by which this 
microbe confers these benefits to its host remain largely 
unresolved (Corr et al., 2007).
The genomic sequence of Lb. salivarius UCC118 re-
vealed a 1.83-Mb chromosome, a 242-kb megaplasmid 
(pMP118), and 2 smaller plasmids. The 242-kb mega-
plasmid is the largest plasmid extracted from a lacto-
bacillus, but no genes encoded on this plasmid were 
deemed essential for the viability of the bacterium. The 
megaplasmid did encode a lactate dehydrogenase for 
d-lactate (cell wall precursor), a bifunctional acetalde-
hyde/alcohol dehydrogenase (only enzyme present to 
catalzye ethanol from acetyl-CoA), a choloylglycine 
hydrolase (bile-salt hydrolase), and a 2-component class 
IIb bacteriocin, Abp118 (Flynn et al., 2002; Claesson 
et al., 2006).
The bacteriocin Abp-118 is small, heat-stable, class 
IIb bacteriocin, whose activity depends on the com-
plementary activity of both peptides (Klaenhammer, 
1993; Flynn et al., 2002). Genetic characterization of 
the 2-component bacteriocin found that Abp-118 is 
composed of Abp118α, which shows antimicrobial ac-
tivity against Lis. monocytogenes, and Abp118β, which 
enhances that activity (Flynn et al., 2002). In a land-
mark study, the ability of Lb. salivarius UCC118, fed 
orally, to protect mice from infection by Lis. monocyto-
genes was evaluated. A 3-d pretreatment of mice with 
Lb. salivarius UCC118 conferred significant protection 
against listerial infection of the liver and spleen. A 
luciferase-based reporter system was integrated into 
the chromosome of Lis. monocytogenes EGDe, and 
luciferase expression was used to follow organ-specific 
colonization of the pathogen in murine liver and spleen 
(Corr et al., 2007)
To investigate if the bacteriocin Abp-118 was the 
primary mediator of protection, a stable mutant of Lb. 
salivarius UCC118 unable to produce the bacteriocin 
was created. The mutant failed to provide protection 
to the mice when challenged with Lis. monocytogenes 
strains L028 and EGDe (Figure 1). This confirmed that 
protection against listerial infection was the result of 
bacteriocin production that directly antagonized Lis. 
monocytogenes in vivo (Corr et al., 2007).
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Cell Surface Adherence Factors
Probiotic bacterial surface proteins have been im-
plicated in the adherence to gastrointestinal epithelial 
cells (Granato et al., 1999), mucin (Rojas et al., 2002), 
and extracellular matrix (ECM) proteins such as fi-
brinogen, fibronectin, and fetuin (Styriak et al., 2003). 
Functional analyses of surface (S) layers have not yet 
definitively determined their significance in adherence 
and retention of probiotics within the GIT. Although 
the genetic mechanisms of adherence of enteropatho-
gens have been well characterized, the genetic mecha-
nisms underlying the adherence of probiotic microbes 
remain to be elucidated (Klaenhammer et al., 2005).
Bacterial adherence structures comprise proteins or 
polysaccharides on the cell surface. Mucin-binding pro-
teins (Mub) selectively adhere to the intestinal mucin 
glycoprotein. Originally isolated from an infant fecal 
sample in 1900 (Klaenhammer and Russell, 2000), Lac-
tobacillus acidophilus is a probiotic strain that is used 
extensively throughout the food industry in dietary 
supplements and cultured yogurt products (Sanders and 
Klaenhammer, 2001). Genomic analysis of Lb. acidophi-
lus NCFM revealed 13 putative proteins that contain 
one or more mucin-binding domains, 3 of which contain 
the necessary components for a complete Mub protein: 
a signal peptide sequence and a LPxTG cell surface 
anchor (Klaenhammer, 2010). Encoded by LBA1392, 
a 4,326-residue Mub protein is the largest encoded 
protein within the Lb. acidophilus NCFM genome (Al-
termann et al., 2005). A conserved putative fibronectin 
(dimeric ECM glycoprotein)-binding protein (Fbp) 
has been found in all Lactobacillus genomes (Goh and 
Klaenhammer, 2009) and Lb. acidophilus NCFM was 
shown to contain FbpA (Altermann et al., 2005). Three 
putative S-layer proteins (Slp), proteinaceous subunits 
that abundantly coat cell surfaces of many eubacteria 
and archaea, were identified and characterized in the 
Lb. acidophilus NCFM genome (SlpA, SlpB, and SlpX; 
Goh et al., 2009).
To determine the importance of genes that are po-
tentially vital for NCFM adherence to the human GIT, 
predicted adherence factors were individually inacti-
vated to determine the effect of single gene products 
on NCFM adherence. Insertionally inactivated mutants 
included FbpA, a mucin-binding protein (encoded by 
LBA1392), and the dominant surface layer protein 
(SlpA) (Buck et al., 2005). Each knockout mutant was 
tested for its abilities to adhere in vitro to Caco-2 intes-
tinal epithelial cells (Figure 2). A significant reduction 
in adherence was observed in the Fbp mutant (76%), 
mucin-binding protein mutant (65%), and in the Slp 
mutant (84%). Functional genomic studies of the Lb. 
acidophilus NCFM adherence factors demonstrated 
that the organism’s ability to adhere to intestinal epi-
thelial cells can be attributed to multiple cell surface 
structures, and no single protein is likely responsible for 
the adherence properties of the cell (Buck et al., 2005; 
Klaenhammer et al., 2005).
Highly homologous surface proteins and adherence 
factors are found throughout Lactobacillus and other 
probiotic species. Lactobacillus reuteri 100-23, a per-
sistent resident of the nonsecretory epithelium of the 
forestomach and gut in mice, encodes an approximately 
185-kDa large surface protein (Lsp) vital for adherence 
to the host epithelium (Walter et al., 2005). Mutational 
phenotypic analysis showed that Lsp has a vital role in 
initiating adherence to the epithelium. Sequence analy-
sis of Lsp revealed a high degree of similarity to Lac-
tobacillus johnsonii NCC 533 and Lactobacillus gasseri 
ATCC 33323 adherence proteins, as well as sequence 
similarity to other gram-positive genes associated with 
epithelial adherence and biofilm production (Walter et 
al., 2005).
Genomic sequencing of Lactobacillus rhamnosus GG 
revealed a pilus as a major cell surface component 
Figure 1. The bacteriocin Abp-118 of Lactobacillus salivarius 
UCC118 was shown to be the primary mediator of protection to mice 
challenged with Listeria monocytogenes strains L028 and EGDe by 
evaluating the protective effects of placebo, UCC118, and UCC118 
(Bac−). Letters above bars indicate statistically significant differences 
between all treatments. Reprinted with permission from Corr et al. 
(2007). Copyright © 2007 National Academy of Sciences, U.S.A.
Journal of Dairy Science Vol. 94 No. 10, 2011
INVITED REVIEW: OMICS TOOLS AND PROBIOTIC FUNCTIONALITY 4757
potentially involved in mucin adherence. Originally 
isolated from a healthy human intestinal sample, Lb. 
rhamnosus GG has been extensively studied and used 
as a probiotic strain in a variety of functional foods 
(Bernardeau et al., 2006; Guarino et al., 2009). When 
incubated together, Lb. rhamnosus and Lactobacillus 
casei Shirota have been shown to competitively exclude 
and displace 8 strains of Escherichia coli and Salmo-
nella spp. from adhering to human intestinal mucus 
glycoproteins and Caco-2 cells (Lee et al., 2003). Pre-
treatment with probiotic Lb. rhamnosus GG results 
in a significant reduction in the ability of Escherichia 
coli O157:H7 (enterohemorrhagic E. coli) to change 
cell morphology, lower electrical resistance, increase 
dextran permeability, and manipulate the distribution 
and expression of tight junction proteins claudin-1 and 
ZO-1 of the mucosal epithelial cell barrier that makes 
up the GIT (Johnson-Henry et al., 2008).
Several studies have compared the adhesion proper-
ties of Lb. rhamnosus GG (a probiotic microbe) and Lb. 
rhamnosus LC705 (an adjunct starter culture in dairy 
products; Suomalainen and Mayra-Makinen, 1999) and 
concluded that Lb. rhamnosus GG was more adherent 
to human cells than Lb. rhamnosus LC705 (Jacobsen 
et al., 1999; Tuomola et al., 2000). To investigate the 
molecular mechanisms possibly involved in adherence 
to intestinal cells and mucin, the complete sequences 
of Lb. rhamnosus GG and Lb. rhamnosus LC705 were 
compared. Within the Lb. rhamnosus GG genome, 
genes encoding 2 different pilus fibers (spaCBA) and 
(spaFED) were identified, whereas the spaCBA operon 
was not found in Lb. rhamnosus LC705. The genes for 
spaCBA were found on an island of genes that secrete 
3 LPxTG-like pilins and a pilin-dedicated sortase 
(Kankainen et al., 2009). The pilus was predicted to 
be a heterotrimer composed of the major pilin or the 
pilus backbone, the minor pilin that covers the pilus 
backbone, and another minor pilin that contains adher-
ence properties (Mandlik et al., 2008; Proft and Baker, 
2009).
Using immunoblotting with anti-SpaC antibodies, the 
physical presence of the pili were confirmed (Figure 3). 
Immunogold electron micrograph shows an average of 
10 to 50 pili per cell located predominantly at the poles, 
with a pilus length of up to 1 μm. Pilin subunit SpaC 
was located primarily at the tip of the pilus, as well as 
sporadically throughout the pilus structure. When Lb. 
rhamnosus GG cells were pretreated with antiserum to 
SpaC, a 10-fold reduction in the overall adherence of 
the cells to mucus was observed.. An insertional mutant 
of Lb. rhamnosus GG (ΩspaC) further confirmed that 
expression of the SpaC protein was required for mucus 
binding by pili (Kankainen et al., 2009).
Interestingly, the Spa-encoded proteins showed con-
siderable similarity to pili from Enterococcus faecium, 
also a commensal resident of the GIT that binds mucin 
(Kankainen et al., 2009). The mucin-binding predispo-
sition of Lb. rhamnosus GG pilus fibers provided sup-
port for a probiotic mechanism of competitive exclusion 
and the potential for steric hindrance of adherence to 
the mucin that lines the epithelial cells of the host GIT 
(Chan et al., 1985; Reid et al., 1985; Isolauri et al., 
2002; Lee et al., 2003).
Stimulation of the Host Immune System
It is now well known that probiotic and commensal 
microbes can modulate host immune responses. How-
ever, the specific mechanisms by which probiotic and 
commensal bacteria modulate the immune responses of 
human epithelial cells has not been defined. Dendritic 
cells (DC), professional antigen-presenting cells, line 
the epithelium of the human GIT and regulate the host 
immune system in response to mucosally encountered 
antigens of the microbiota and viruses. Dendritic cells 
are responsible for recognizing exogenous and en-
dogenous stimuli and responding to those signals by 
eliciting the correct innate and adaptive response or 
tolerance (Smits et al., 2005; van Vliet et al., 2007). 
Immature DC migrate from the bloodstream to specific 
compartments within the GIT to directly interact with 
structures of pathogenic and nonpathogenic bacteria 
Figure 2. Percentages of adhesion properties of Lactobacillus aci-
dophilus NCFM and insertionally inactivated mutants of fibronectin-
binding protein A (FbpA), mucin-binding protein (Mub), and sur-
face layer protein A (SlpA), enumerated microscopically. Error bars 
represent 1 SD. Reprinted with permission from Buck et al. (2005). 
Copyright © American Society for Microbiology, Applied Environmental 
Microbiology (2005) 71:8344–8351.
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and viruses that protrude through the mucosal barrier 
(Smits et al., 2005). Dendritic cells mature phenotypi-
cally and functionally in response to the external stim-
uli of the gastrointestinal environment by upregulating 
expression of a pattern recognition receptor on the cell 
surface, producing inflammatory chemokines and cyto-
kines, and differentiating naive helper T cells into Th1 
and Th2 cells (Mohamadzadeh et al., 2005; Kabelitz 
and Medzhitov, 2007).
Toll-like receptors (TLR) and C-type lectins (CLR) 
are examples of pattern recognition receptors that rec-
ognize specific microbial molecular patterns of interact-
ing compounds such as carbohydrates, lipids, nucleic 
acids, and proteins (Weis et al., 1998). Toll-like recep-
tors communicate information from interacting mi-
crobial compounds to DC through signaling cascades, 
eliciting cellular processes such as DC maturation and 
inducing proinflammatory cytokines (e.g., IL-12, IFNγ; 
Underhill and Ozinsky, 2002). Unlike TLR, CLR are 
formed without the induction of DC maturation and 
bind to mannose- and fucose-containing glycan ligands 
in a calcium-dependent manner (Engering et al., 2002).
Strains of Lactobacillus plantarum contain carbo-
hydrate-protein surface structures such as mannose-
specific adhesins that have been shown to bind to hu-
man colonic cells (Adlerberth et al., 1996). Candidate 
mannose-specific adhesion genes of Lb. plantarum 
WCFS1 were investigated by gene-specific deletion and 
overexpression systems. The sortase-dependent cell 
surface protein Msa (mannose-specific adhesion) was 
identified as having carbohydrate-binding domains and 
is likely involved in the interaction of Lb. plantarum 
with the host GIT (Pretzer et al., 2005).
Studying the adherence of Lb. acidophilus NCFM cell 
surface components to DC using a functional genomic 
approach revealed that the interaction between the 
receptor and ligand induced concentration-dependent 
production of IL-10 and low IL-12p70. Receptor–ligand 
interactions were studied to determine the specific mo-
lecular mechanisms that influence cytokine production 
and sequestering of differentiated helper T cells. Using 
an ELISA, the bacterium was shown to bind to a DC-
specific ICAM-3-grabbing nonintegrin (DC-SIGN), a 
CLR that recognizes mannose- and fructose-containing 
glycans on microbial and viral surfaces. A knockout 
mutant in NCFM of the major surface layer A protein 
(SlpA) showed a significant reduction in DC-SIGN 
binding (Konstantinov et al., 2008). The SlpA mutant 
incurred a chromosomal inversion causing the slpB gene 
(the normally silent gene located downstream and in 
the opposite orientation of the slpA gene) to invert di-
rectly behind the S-promoter and begin expression of 
SlpB protein (Boot et al., 1996).
Binding of the SlpB-dominant strain (the SlpA 
knockout) with DC elicited a different response from 
the SlpA-dominant parent: increased production of 
proinflammatory cytokines IL-12p70, tumor necrosis 
factor-α (TNFα), and IL-1β. The parent NCFM strain 
was shown to stimulate T cells to produce more IL-4 
than the SlpA-knockout mutant. Direct ligation of pu-
rified SlpA protein and DC-SIGN confirmed that the 
SlpA of Lb. acidophilus NCFM was the first probiotic 
DC-SIGN ligand identified and that it is directly in-
volved in the immunomodulation of DC and helper T 
cells (Konstantinov et al., 2008). Probiotic stimulation 
of intestinal epithelium to produce cytokine TNFα has 
Figure 3. Transmission electron microscopy showing negatively 
stained immunogold-labeled anti-SpaC pili subunits of Lactobacillus 
rhamnosus GG. Reprinted with permission from Kankainen et al. 
(2009). Copyright © 2009 National Academy of Sciences, U.S.A.
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been shown to promote gut health by restoring epithe-
lial barrier functions in vivo (Pagnini et al., 2010).
Lactobacillus plantarum is commonly found on plants 
and is widely used in vegetable fermentations. With the 
entire genome sequenced, Lb. plantarum WCFS1 is ac-
cessible to genetic modifications and allows for specific 
bacterial compounds to be studied for possible interac-
tions with the host immune system (Kleerebezem et 
al., 2003). Components of the cell wall of gram-positive 
bacteria, such as teichoic acids (TA) and especially li-
poteichoic acids (LTA), have been shown to induce the 
production of cytokines within host cells (Morath et al., 
2001). Lipoteichoic acids have been shown to stimulate 
TNFα in human macrophages and have been proposed 
to function in the adhesion of lactobacilli to epithelial 
cells (Sherman and Savage, 1986; Granato et al., 1999). 
Utilizing comparative genomic hybridization of Lb. 
plantarum strains, specific gene loci within Lb. plan-
tarum WCFS1 were identified as candidate genes for 
the modulation of the host immune system. Subsequent 
gene deletions of the candidate genes confirmed that 3 
bacteriocin and 1 transcriptional regulator loci have an 
immunomodulatory effect on the DC (Meijerink et al., 
2010). To further elucidate the bioactive components of 
the probiotic cell surface that have immunomodulatory 
functions, the importance of the specific TA composi-
tion and the importance of LTA in probiotic functional-
ity were studied in Lb. plantarum WCFS1 (Grangette 
et al., 2005).
Using a suicide knockout vector, a single-step ho-
mologous recombination that disrupted the dlt operon 
(genes responsible for the d-alanylation of TA) was per-
formed to produce a mutant strain with LTA deficient 
in d-alanine (Dlt− mutant). After peripheral blood 
mononuclear cells and monocytes were exposed to the 
Dlt− mutant and the parent strain, comparisons of the 
cytokine profiles showed that the Dlt− mutant caused 
a significant reduction in the secretion of proinflamma-
tory cytokine IL-12 and greatly induced the secretion of 
the antiinflammatory cytokine IL-10 (Grangette et al., 
2005). The proinflammatory ability of Lb. plantarum 
LTA was determined to be dependent on TLR2 (Gran-
gette et al., 2005); TLR2 has been shown to stimulate 
the secretion of IL-12 in response to interactions with 
double-stranded RNA and a potential viral attack 
(Weiss et al., 2010). This functional genomics study 
showed that the specific changes to the composition of 
Lb. plantarum LTA could vary cytokine secretion and 
modulate the overall immune response (Grangette et 
al., 2005).
To study the involvement of LTA in the induction 
and repression of intestinal inflammation, the phospho-
glycerol transferase (key enzyme in LTA biosynthesis) 
of Lb. acidophilus NCFM was deleted. When exposed to 
the LTA-negative cells (NCK 2025), DC of mice showed 
a reduction in the release of cytokines IL-12 and TNFα, 
an increase in IL-10 secretion, and an overall reduc-
tion in immune response within the cells. The overall 
reduction in immune response was evident by the in-
ability of DC to sequester and activate CD4+ T cells 
(Mohamadzadeh et al., 2011). When comparing the 
efficacy of strains NCK 2025 and NCFM to alleviate 
dextran sulfate sodium (DSS)-induced and pathogenic 
CD4+CD45RBhigh T cell-induced colitis, NCK 2025 was 
shown to significantly reduce the severity of colitis and 
effectively alleviated DSS-induced colitis via elicited 
IL-10 and CD4+FoxP3+ regulatory T cells to lessen the 
exacerbated inflammation of the epithelium. Intestinal 
samples collected from the experimental mice showed 
differences in the amelioration of DSS-induced colitis in 
the control (DSS-treated mice), NCFM-DSS–treated, 
and NCK2025-DSS–treated mice (Figure 4). These 
studies established that directed alterations and engi-
neering of probiotic cell surface structures is a potential 
strategy for therapeutic treatment of colitis and other 
inflammatory gastrointestinal disorders (Grangette et 
al., 2005; Mohamadzadeh et al., 2011).
Influence of Dairy Environment on Gene Expression
Despite the need for scientific understanding to pro-
vide regulatory substantiation of the benefits of probi-
otics used in foods, the effects of the food matrix and 
product formulation on the viability and functionality 
of probiotic microbes are relatively unknown (Sanders 
and Marco, 2010). To investigate the differences in gene 
expression and probiotic attributes of Lb. acidophilus 
NCFM when propagated in milk (the most common 
platform of probiotic delivery), whole-genome microar-
rays of the temporal gene expression of NCFM cells 
were performed. The Lb. acidophilus NCFM cells were 
propagated in 11% milk during the early, mid, and late 
logarithmic phases and the stationary phase to deter-
mine the potential effect of a dairy environment on 
probiotics (Azcarate-Peril et al., 2009).
After analyzing the differences in gene expression 
during growth in milk, 21% of the 1,864 open read-
ing frames were differentially expressed in at least 
one time point. The expression of genes involved in 
carbohydrate utilization were rapidly induced in early 
stages of growth and decreased over time, as the main 
carbohydrate sources became depleted. The decreased 
expression of carbohydrate utilization genes tended to 
coincide with increased expression of key components 
of carbon catabolite repression systems, which control 
the transcription of genes involved in the transport 
and catabolism of carbohydrates. Expression patterns 
of proteolytic genes increased consistently over time, 
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whereas the 2 oligopeptide transporter genes, opp1 and 
opp2, showed 2 different maximum expression levels, 
one in the early logarithmic phase and the other in 
the stationary phase, respectively (Azcarate-Peril et 
al., 2009). Lactobacillus acidophilus NCFM showed 
temporal expression patterns peaking at 12 h (early 
stationary phase) for 16 peptidases. Peptidases such 
as PepF, which are able to hydrolyze large peptides, 
were shown to have high early expression, followed by 
decreased expression as other peptidases that hydrolyze 
smaller peptides began to increase in expression levels. 
Expression of stress-related (LacL) and quorum-sensing 
(luxS) genes were shown to increase as growth pro-
gressed, the number of cells increased, and lactic acid 
accumulated. Using NCFM mutants that contained 
insertionally inactivated genes, adherence assays were 
able to determine the possible importance of 2 NCFM 
genes (LBA1690 and LBA1524HPK) to promote muco-
sal and cell adherence during NCFM growth in milk..
One gene that was overexpressed during growth in milk 
was an aggregation-promoting factor (Apf; Azcarate-
Peril et al., 2009). Sequence analysis of Lb. acidophilus 
NCFM identified LBA0493 as a 696-bp apf gene that 
encodes a putative 21-kDa Apf protein (Altermann et 
al., 2005). Transcriptional studies determined the apf 
gene to be one of the most differentially upregulated (5 
times the normalized value) genes in milk (Azcarate-
Peril et al., 2009). Aggregation-promoting factors and 
the genes that encode them have been characterized 
for several Lactobacillus species; some of these proteins 
have been shown to be major aggregation factors, 
whereas others are not directly involved in aggregation 
of bacteria. The Apf have been reported to influence 
coaggregation with specific pathogens (Schachtsiek et 
al., 2004), enhance conjugation efficiency (Reniero et 
al., 1992), and maintain cell shape similarly to S-layer 
proteins (Jankovic et al., 2003).
Reverse transcription-quantitative PCR analysis was 
used to determine that the apf gene was most highly in-
duced during the stationary phase. Mutational analysis 
of the apf gene was used to study the functional roles of 
Apf in Lb. acidophilus NCFM (Goh and Klaenhammer, 
2010). An Δapf mutant was constructed using an upp-
based counterselective gene replacement system, utiliz-
ing the upp-encoded uracil phosphoribosyltransferase 
(UPRTase) as a counterselection marker to positively 
select for single crossover plasmid integrants without 
the use of antibiotics for selective pressure (Goh et 
al., 2009). A comparison of the cell morphologies of 
Lb. acidophilus NCFM with and without the apf gene 
showed no detectable differences. The Δapf mutant 
also showed no effect on the sedimentation and autoag-
gregation of NCFM. However, inactivation of the apf 
locus increased susceptibility of NCFM to 2.5% oxgall 
Figure 4. Intestinal samples collected from the experimental mice 
show the differences in the amelioration of dextran sulfate sodium 
(DSS)-induced colitis in the (B) control (DSS-treated mice); (C) 
Lactobacillus acidophilus NCFM (NCK56) DSS–treated mice, and D) 
Lb. acidophilus NCFM LTA-negative (NCK2025) DSS–treated mice. 
Panel A (from original; not shown here) showed the treatment sched-
ule of the experimental mice and graphs of the percentage body weight 
change, fecal hemoccult blood positivity, disease activity index, and 
diarrhea score of each treatment throughout the experiment. Color 
version available in the online PDF. Reprinted with permission from 
Mohamadzadeh et al. (2011).
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(bile salt reduced survival), and 0.02% SDS (reduced 
survival and altered cell morphology). The Δapf mu-
tant was shown to be more susceptible to simulated 
small-intestinal juice (4 log reduction after 3-h incuba-
tion) and to simulated gastric juice (1 log reduction 
after 1-h incubation). The adherence ability of Δapf 
mutant was examined on Caco-2 epithelial cells, mucin, 
and the ECM components collagen IV, laminin, and 
fibronectin. A reduction in adherence was observed 
for Caco-2 cells (30%), mucin (36.5%), and fibronectin 
(40%). Although the study did not show Apf to be 
an important factor in cell aggregation, the apf gene 
was demonstrated to be highly expressed in the dairy 
environment and to play an important role in promot-
ing bile tolerance, survival in the GIT, and interactions 
with the mucus layer, epithelial cells, and fibronectin 
(Goh and Klaenhammer, 2010).
Developing Novel Probiotic Functionality
With increased knowledge of mechanisms of action 
and gene expression, probiotic cellular structures can 
be modified to potentially increase their protective 
functionality in the host. Effective vaccines confer 
protection to recipients against pathogenic microbes 
by potentiating antibody avidity and boosting the 
longevity and number of T cells. Although live attenu-
ated pathogens such as Salmonella, Bordetella, and 
Listeria have been successfully used as vaccine vec-
tors, the potential for virulent reversion within these 
strains limits their practical application (Roberts et 
al., 2000; Saklani-Jusforgues et al., 2003; Stevenson 
and Roberts, 2003). Once inside a host, Bacillus an-
thracis produces the anthrax toxin, which causes sys-
temic infections with 100% mortality (Inglesby et al., 
1999; Tournier and Mohamadzadeh, 2008). Multiple 
subcutaneous injections of aluminum hydroxide (alhy-
drogel) are currently used as the vaccination against 
B. anthracis infection; however, this vaccine regimen 
causes significant transient side effects (Pittman et 
al., 2002). Lactic acid bacteria have been studied 
as possible vaccine vectors because they are GRAS 
(“generally regarded as safe”) organisms that can 
survive passage through the GIT, induce regulated 
inflammatory responses against infections, increase 
IgA production, and activate monocytic lineages 
(Mohamadzadeh and Klaenhammer, 2008) . A novel 
oral vaccine strategy was developed, utilizing Lb. aci-
dophilus to deliver expressed B. anthracis protective 
antigen (PA) via DC-targeting peptides (PA-DCpep 
fusion proteins) to DC residing in the submucosal lay-
ers of the GIT (Mohamadzadeh et al., 2009).
Figure 5. Experimental mice were fed PBS, Lactobacillus gasseri (empty vector), Lb. gasseri expressing Bacillus anthracis protective antigen 
fused to control peptide (PA-Ctrlpep), and Lb. gasseri expressing B. anthracis protective antigen fused to a dendritic cell-binding peptide (PA-
DCpep) for 3 wk before challenge with B. anthracis (anthrax) Sterne. In the days following a lethal challenge of Sterne, the percentage survival 
for each group was monitored. Reprinted with permission from Mohamadzadeh et al. (2010).
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The Lb. acidophilus PA-DCpep vaccine efficiency 
was evaluated in mice challenged with B. anthracis 
Sterne. Compared with the mice vaccinated with Lb. 
acidophilus expressing PA-control peptide or an empty 
vector, the Lb. acidophilus PA-DCpep induced robust 
protective immunity and comparable anti-PA titers and 
levels of IgA-expressing cells to that of the aluminum 
hydroxide vaccine. After monitoring for 40 d, the sur-
vival rates of the experimental groups were 80% for 
aluminum hydroxide vaccine, 75% for Lb. acidophilus 
PA-DCpep vaccine, 25% for Lb. acidophilus PA-Ctrlpep 
vaccine, and no survival for Lb. acidophilus (empty vec-
tor) and control groups (Mohamadzadeh et al., 2009).
To improve the efficacy of the oral probiotic-based 
vaccine, PA-DCpep was inserted into a stable, high-
copy θ-replicating plasmid (pTRKH2) and expressed in 
Lb. gasseri. The genetically accessible Lb. gasseri has 
been sequenced and extensively studied for its use as a 
human probiotic and commensal species of the human 
GIT and vagina (Mohamadzadeh et al., 2010). After oral 
administration of Lb. gasseri expressing PA-DCpep, the 
fusion proteins elicited an effective PA-neutralizing and 
T-cell mediated immune response that resulted in 100% 
survival to B. anthracis Sterne infections (Figure 5). An 
orally administered Lactobacillus-based vaccine offers 
many advantages to recipients, such as reduced tran-
sient side effects and no need for potentially harmful 
chemical coupling agents (Mohamadzadeh et al., 2010).
The advancements in omics tools were responsible 
for the ability to direct genetic modifications in these 
probiotic lactobacilli. The development of probiotic-
based vaccines shows promise as a means to deliver 
safe and effective protective immunity against human 
pathogens.
CONCLUSIONS
The recent advancements in sequencing technology 
and functional omics techniques have provided greater 
insights into the specific mechanisms underlying probi-
otic functionality. The developing comprehension of the 
human gut microbiome will allow proper characteriza-
tion of probiotic effects on the commensal microbiota of 
humans in vivo. Identification of genes vital to probiotic 
functionality is providing researchers the ability to ge-
netically tailor probiotics to meet the needs for specific 
applications. Recent studies have shown the effective 
use of probiotics in preventive medicine, maintaining 
the microbiota and host physiology of a healthy GIT, 
and the remediation of inflammatory bowel diseases, 
as well as the potential use of probiotic-based vaccine 
delivery systems. Future clinical trials are required to 
fully elucidate the therapeutic potential of probiotics 
in humans.
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